Top

Published in:

Open Access 01-12-2016 | Original Research

Osthole Promotes Endochondral Ossification and Accelerates Fracture Healing in Mice

Authors: Zhongrong Zhang, Wing Nang Leung, Gang Li, Yau Ming Lai, Chun Wai Chan

Published in: Calcified Tissue International | Issue 6/2016

Abstract

Osthole has been found to restore bone mass in preclinical osteoporotic models. In the present study, we investigated the effects of osthole on bone fracture repair in mice. Adult C57BL/6 mice were subjected to transverse femoral fractures and administrated orally with 20 mg/kg osthole and vehicle solvent daily from week 1 post-operation. Fracture callus were analyzed by plain radiography, micro-computed tomography, histology, molecular imaging and immunohistochemistry and tartrate-resistant acid phosphatase staining. Results demonstrated that osthole treatment enhanced removal of cartilage and bony union during reparative stage without significant interfering on remodeling process. In vivo molecular imaging showed bone formation rate of the treatment group was almost twofold of control group at week 2 post-operation. Osthole augmented the expression of alkaline phosphatase and collagen type X in hypertrophic chondrocytes as well as expression of bone morphogenetic protein-2, osteocalcin and alkaline phosphatase in osteoblastic cells, indicating it promoted mineralization of hypertrophic cartilage and woven bone growth simultaneously during endochondral healing. In summary, osthole promotes endochondral ossification via upregulation of maturation osteogenic marker genes in chondrocytes and subsequently accelerates fracture repair and bony fusion.

Chan CW, Qin L, Lee KM, Cheung WH, Cheng JC, Leung KS (2006) Dose-dependent effect of low-intensity pulsed ultrasound on callus formation during rapid distraction osteogenesis. J Orthop Res 24(11):2072–2079. doi:10.1002/jor.20258 CrossRefPubMed

He YX, Zhang G, Pan XH, Liu Z, Zheng LZ, Chan CW, Lee KM, Cao YP, Li G, Wei L, Hung LK, Leung KS, Qin L (2011) Impaired bone healing pattern in mice with ovariectomy-induced osteoporosis: a drill-hole defect model. Bone 48(6):1388–1400. doi:10.1016/j.bone.2011.03.720 CrossRefPubMed

Zhou XZ, Zhang G, Dong QR, Chan CW, Liu CF, Qin L (2009) Low-dose X-irradiation promotes mineralization of fracture callus in a rat model. Arch Orthop Trauma Surg 129(1):125–132. doi:10.1007/s00402-008-0634-6 CrossRefPubMed

Riggs BL, Melton LJ III (1995) The worldwide problem of osteoporosis: insights afforded by epidemiology. Bone 17(5 Suppl):505S–511SCrossRefPubMed

Reginster JY, Burlet N (2006) Osteoporosis: a still increasing prevalence. Bone 38(2 Suppl 1):S4–S9. doi:10.1016/j.bone.2005.11.024 CrossRefPubMed

Gallacher SJ, Dixon T (2010) Impact of treatments for postmenopausal osteoporosis (bisphosphonates, parathyroid hormone, strontium ranelate, and denosumab) on bone quality: a systematic review. Calcif Tissue Int 87(6):469–484. doi:10.1007/s00223-010-9420-x CrossRefPubMed

Rodan GA, Martin TJ (2000) Therapeutic approaches to bone diseases. Science 289(5484):1508–1514CrossRefPubMed

Baron R, Ferrari S, Russell RG (2011) Denosumab and bisphosphonates: different mechanisms of action and effects. Bone 48(4):677–692. doi:10.1016/j.bone.2010.11.020 CrossRefPubMed

Kennel KA, Drake MT (2009) Adverse effects of bisphosphonates: implications for osteoporosis management. Mayo Clin Proc 84(7):632–637. doi:10.1016/S0025-6196(11)60752-0 (quiz 638) CrossRefPubMedPubMedCentral

10.

Sellmeyer DE (2010) Atypical fractures as a potential complication of long-term bisphosphonate therapy. JAMA 304(13):1480–1484. doi:10.1001/jama.2010.1360 CrossRefPubMed

11.

Gerstenfeld LC, Sacks DJ, Pelis M, Mason ZD, Graves DT, Barrero M, Ominsky MS, Kostenuik PJ, Morgan EF, Einhorn TA (2009) Comparison of effects of the bisphosphonate alendronate versus the RANKL inhibitor denosumab on murine fracture healing. J Bone Miner Res 24(2):196–208. doi:10.1359/jbmr.081113 CrossRefPubMed

12.

Yu YY, Lieu S, Hu D, Miclau T, Colnot C (2012) Site specific effects of zoledronic acid during tibial and mandibular fracture repair. PLoS One 7(2):e31771. doi:10.1371/journal.pone.0031771 CrossRefPubMedPubMedCentral

13.

Jabbour Z, El-Hakim M, Henderson JE, de Albuquerque RF Jr (2014) Bisphosphonates inhibit bone remodeling in the jaw bones of rats and delay healing following tooth extractions. Oral Oncol 50(5):485–490. doi:10.1016/j.oraloncology.2014.02.013 CrossRefPubMed

14.

Suntar I, Akkol EK (2013) Beneficial effects of plant sources on the treatment of osteoporosis. Curr Drug Targets 14(13):1611–1618CrossRefPubMed

15.

Li QN, Liang NC, Wu T, Wu Y, Xie H, Huang GD, Mo LE (1994) Effects of total coumarins of Fructus cnidii on skeleton of ovariectomized rats. Zhongguo Yao Li Xue Bao 15(6):528–532PubMed

16.

Liao JM, Zhu QA, Lu HJ, Li QN, Wu T, Huang LF (1997) Effects of total coumarins of Cnidium monnieri on bone density and biomechanics of glucocorticoids-induced osteoporosis in rats. Zhongguo Yao Li Xue Bao 18(6):519–521PubMed

17.

Zhang ZR, Leung WN, Cheung HY, Chan CW (2015) Osthole: a review on its bioactivities, pharmacological properties, and potential as alternative medicine. Evid Based Complement Alternat Med 2015:919616. doi:10.1155/2015/919616 PubMedPubMedCentral

18.

Li XX, Hara I, Matsumiya T (2002) Effects of osthole on postmenopausal osteoporosis using ovariectomized rats; comparison to the effects of estradiol. Biol Pharm Bull 25(6):738–742CrossRefPubMed

19.

Tang DZ, Hou W, Zhou Q, Zhang M, Holz J, Sheu TJ, Li TF, Cheng SD, Shi Q, Harris SE, Chen D, Wang YJ (2010) Osthole stimulates osteoblast differentiation and bone formation by activation of β-catenin-BMP signaling. J Bone Miner Res 25(6):1234–1245. doi:10.1002/jbmr.21 CrossRefPubMedPubMedCentral

20.

Kuo PL, Hsu YL, Chang CH, Chang JK (2005) Osthole-mediated cell differentiation through bone morphogenetic protein-2/p38 and extracellular signal-regulated kinase 1/2 pathway in human osteoblast cells. J Pharmacol Exp Ther 314(3):1290–1299. doi:10.1124/jpet.105.085092 CrossRefPubMed

21.

Ming LG, Zhou J, Cheng GZ, Ma HP, Chen KM (2011) Osthol, a coumarin isolated from common cnidium fruit, enhances the differentiation and maturation of osteoblasts in vitro. Pharmacology 88(1–2):33–43. doi:10.1159/000328776 CrossRefPubMed

22.

He YX, Liu Z, Pan XH, Tang T, Guo BS, Zheng LZ, Xie XH, Wang XL, Lee KM, Li G, Cao YP, Wei L, Chen Y, Yang ZJ, Hung LK, Qin L, Zhang G (2012) Deletion of estrogen receptor beta accelerates early stage of bone healing in a mouse osteotomy model. Osteoporos Int 23(1):377–389. doi:10.1007/s00198-011-1812-x CrossRefPubMed

23.

Tower RJ, Campbell GM, Muller M, Will O, Gluer CC, Tiwari S (2014) Binding kinetics of a fluorescently labeled bisphosphonate as a tool for dynamic monitoring of bone mineral deposition in vivo. J Bone Miner Res 29(9):1993–2003. doi:10.1002/jbmr.2224 CrossRefPubMed

24.

Hao YJ, Zhang G, Wang YS, Qin L, Hung WY, Leung K, Pei FX (2007) Changes of microstructure and mineralized tissue in the middle and late phase of osteoporotic fracture healing in rats. Bone 41(4):631–638. doi:10.1016/j.bone.2007.06.006 CrossRefPubMed

25.

Bonvin E, Le Rouzic P, Bernaudin JF, Cottart CH, Vandebrouck C, Crie A, Leal T, Clement A, Bonora M (2008) Congenital tracheal malformation in cystic fibrosis transmembrane conductance regulator-deficient mice. J Physiol 586(Pt 13):3231–3243. doi:10.1113/jphysiol.2008.150763 CrossRefPubMedPubMedCentral

26.

Ke HZ, Richards WG, Li X, Ominsky MS (2012) Sclerostin and Dickkopf-1 as therapeutic targets in bone diseases. Endocr Rev 33(5):747–783. doi:10.1210/er.2011-1060 CrossRefPubMed

27.

Histing T, Garcia P, Holstein JH, Klein M, Matthys R, Nuetzi R, Steck R, Laschke MW, Wehner T, Bindl R, Recknagel S, Stuermer EK, Vollmar B, Wildemann B, Lienau J, Willie B, Peters A, Ignatius A, Pohlemann T, Claes L, Menger MD (2011) Small animal bone healing models: standards, tips, and pitfalls results of a consensus meeting. Bone 49(4):591–599. doi:10.1016/j.bone.2011.07.007 CrossRefPubMed

28.

Hoult JR, Paya M (1996) Pharmacological and biochemical actions of simple coumarins: natural products with therapeutic potential. Gen Pharmacol 27(4):713–722CrossRefPubMed

29.

Yun F, Kang A, Shan J, Zhao X, Bi X, Li J, Di L (2014) Preparation of osthole-polymer solid dispersions by hot-melt extrusion for dissolution and bioavailability enhancement. Int J Pharm 465(1–2):436–443. doi:10.1016/j.ijpharm.2014.02.040 CrossRefPubMed

30.

Zaheer A, Lenkinski RE, Mahmood A, Jones AG, Cantley LC, Frangioni JV (2001) In vivo near-infrared fluorescence imaging of osteoblastic activity. Nat Biotechnol 19(12):1148–1154. doi:10.1038/nbt1201-1148 CrossRefPubMed

31.

Frangioni JV (2003) In vivo near-infrared fluorescence imaging. Curr Opin Chem Biol 7(5):626–634CrossRefPubMed

32.

Leboy PS, Vaias L, Uschmann B, Golub E, Adams SL, Pacifici M (1989) Ascorbic acid induces alkaline phosphatase, type X collagen, and calcium deposition in cultured chick chondrocytes. J Biol Chem 264(29):17281–17286PubMed

33.

Bahrami S, Plate U, Dreier R, DuChesne A, Willital GH, Bruckner P (2001) Endochondral ossification of costal cartilage is arrested after chondrocytes have reached hypertrophic stage of late differentiation. Matrix Biol 19(8):707–715CrossRefPubMed

34.

Randau TM, Schildberg FA, Alini M, Wimmer MD, el Haddouti M, Gravius S, Ito K, Stoddart MJ (2013) The effect of dexamethasone and triiodothyronine on terminal differentiation of primary bovine chondrocytes and chondrogenically differentiated mesenchymal stem cells. PLoS One 8(8):e72973. doi:10.1371/journal.pone.0072973 CrossRefPubMedPubMedCentral

35.

Kozhemyakina E, Lassar AB, Zelzer E (2015) A pathway to bone: signaling molecules and transcription factors involved in chondrocyte development and maturation. Development 142(5):817–831. doi:10.1242/dev.105536 CrossRefPubMedPubMedCentral

36.

Caron MM, Emans PJ, Cremers A, Surtel DA, Coolsen MM, van Rhijn LW, Welting TJ (2013) Hypertrophic differentiation during chondrogenic differentiation of progenitor cells is stimulated by BMP-2 but suppressed by BMP-7. Osteoarthritis Cartilage 21(4):604–613. doi:10.1016/j.joca.2013.01.009 CrossRefPubMed

37.

Zhang Q, Qin L, He W, Van Puyvelde L, Maes D, Adams A, Zheng H, De Kimpe N (2007) Coumarins from Cnidium monnieri and their antiosteoporotic activity. Planta Med 73(1):13–19. doi:10.1055/s-2006-951724 CrossRefPubMed

38.

Grano M, Colucci S, Cantatore FP, Teti A, Zambonin Zallone A (1990) Osteoclast bone resorption is enhanced in the presence of osteoblasts. Boll Soc Ital Biol Sper 66(11):1051–1057PubMed

39.

Teti A, Grano M, Colucci S, Argentino L, Zambonin ZA (1990) Osteoblast-osteoclast interaction in bone resorption. Preliminary results. Boll Soc Ital Biol Sper 66(5):427–431PubMed

40.

Soung DY, Gentile MA, Duong LT, Drissi H (2013) Effects of pharmacological inhibition of cathepsin K on fracture repair in mice. Bone 55(1):248–255. doi:10.1016/j.bone.2013.02.010 CrossRef

41.

Andreassen TT, Ejersted C, Oxlund H (1999) Intermittent parathyroid hormone (1–34) treatment increases callus formation and mechanical strength of healing rat fractures. J Bone Miner Res 14(6):960–968. doi:10.1359/jbmr.1999.14.6.960 CrossRefPubMed

42.

Skripitz R, Andreassen TT, Aspenberg P (2000) Parathyroid hormone (1–34) increases the density of rat cancellous bone in a bone chamber. A dose-response study. J Bone Joint Surg Br 82(1):138–141CrossRefPubMed

43.

Ellegaard M, Jorgensen NR, Schwarz P (2010) Parathyroid hormone and bone healing. Calcif Tissue Int 87(1):1–13. doi:10.1007/s00223-010-9360-5 CrossRefPubMed

44.

Tobimatsu T, Kaji H, Sowa H, Naito J, Canaff L, Hendy GN, Sugimoto T, Chihara K (2006) Parathyroid hormone increases β-catenin levels through Smad3 in mouse osteoblastic cells. Endocrinology 147(5):2583–2590. doi:10.1210/en.2005-1627 CrossRefPubMed

45.

Inoue Y, Canaff L, Hendy GN, Hisa I, Sugimoto T, Chihara K, Kaji H (2009) Role of Smad3, acting independently of transforming growth factor-β, in the early induction of Wnt-β-catenin signaling by parathyroid hormone in mouse osteoblastic cells. J Cell Biochem 108(1):285–294. doi:10.1002/jcb.22252 CrossRefPubMed

46.

Tian Y, Xu Y, Fu Q, He M (2011) Parathyroid hormone regulates osteoblast differentiation in a Wnt/β-catenin-dependent manner. Mol Cell Biochem 355(1–2):211–216. doi:10.1007/s11010-011-0856-8 CrossRefPubMed

Title: Osthole Promotes Endochondral Ossification and Accelerates Fracture Healing in Mice
Authors: Zhongrong Zhang
Wing Nang Leung
Gang Li
Yau Ming Lai
Chun Wai Chan
Publication date: 01-12-2016
Publisher: Springer US
Published in: Calcified Tissue International / Issue 6/2016
Print ISSN: 0171-967X
Electronic ISSN: 1432-0827
DOI: https://doi.org/10.1007/s00223-016-0189-4

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2016

Laser-Sintered Constructs with Bio-inspired Porosity and Surface Micro/Nano-Roughness Enhance Mesenchymal Stem Cell Differentiation and Matrix Mineralization In Vitro

Bone Mass Distribution of the Distal Tibia in Normal, Osteopenic, and Osteoporotic Conditions: An Ex Vivo Assessment Using HR-pQCT, DXA, and Computational Modelling

Associations Between Body Composition and Bone Health in Children and Adolescents: A Systematic Review

Bone Metabolism and the c.-223C > T Polymorphism in the 5′UTR Region of the Osteoprotegerin Gene in Patients with Inflammatory Bowel Disease

Associations Between Fat Mass, Lean Mass, and Knee Osteoarthritis: The Fifth Korean National Health and Nutrition Examination Survey (KNHANES V)

The Role of Tumor Necrosis Factor Alpha and TNF Superfamily Members in Bone Damage in Patients with End-Stage Chronic Obstructive Lung Disease Prior to Lung Transplantation

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage